SEC Form 4 · accession 0000899243-18-022309
BIODELIVERY SCIENCES INTERNATIONAL INC · BDSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott M. Plesha
Officer — President
Period of report
Aug 10, 2018
Accepted (ET)
Aug 14, 2018 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001103021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 10, 2018 | M | 36,432 | $0.00 | A | 193,588 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | $0.00 | Aug 10, 2018 | M | 36,432 | D | — | Aug 10, 2018 | Common Stock | 36,432 | 0 | D |
Explanation of responses
- F1The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the Restricted Stock Units ("RSUs") granted to the Reporting Person on August 10, 2015 under the Issuer's 2011 Equity Incentive Plan, as amended. Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock.